{"nct_id":"NCT06003231","title":"A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-11-14","start_date_type":"ACTUAL","primary_completion_date":"2026-05-31","primary_completion_date_type":"ESTIMATED","completion_date":"2028-05-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}